Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne L Epstein

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Virology|May 31, 2022
Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require AntibodiesGraeme E Price, Chia-Yun Lo, Julia A Misplon, et al.
Plos One|April 8, 2016
Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in MiceMayra García, Julia A Misplon, Graeme E Price, et al.
Journal of Virology|October 13, 2023
Adenoviral-vectored universal influenza vaccines administered intranasally reduce lung inflammatory responses upon viral challenge 15 months post-vaccinationJulia A Misplon, Chia-Yun Lo, Torrie A Crabbs, et al.
Vaccine|July 6, 2010
Genetic control of immune responses to influenza A matrix 2 protein (M2)Julia A Misplon, Chia-Yun Lo, Jon D Gabbard, et al.
Vaccine|July 6, 2021
Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in miceChia-Yun Lo, Julia A Misplon, Xing Li, et al.
Vaccine|December 19, 2017
Conventional influenza vaccines influence the performance of a universal influenza vaccine in miceJanelle Rowell, Chia-Yun Lo, Graeme E Price, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 11, 2011
Intranasal administration of adeno-associated virus type 12 (AAV12) leads to transduction of the nasal epithelia and can initiate transgene-specific immune responseKathrina Quinn, Mary R Quirion, Chia-Yun Lo, et al.
Vaccine|July 14, 2005
Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoproteinSuzanne L Epstein, Wing-pui Kong, Julia A Misplon, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2012
Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenzaNimalan Arinaminpathy, Oliver Ratmann, Katia Koelle, et al.
Plos One|April 16, 2019
The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in miceJanelle Rowell, Chia-Yun Lo, Graeme E Price, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Virology|May 31, 2022
Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require AntibodiesGraeme E Price, Chia-Yun Lo, Julia A Misplon, et al.
Plos One|April 8, 2016
Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in MiceMayra García, Julia A Misplon, Graeme E Price, et al.
Journal of Virology|October 13, 2023
Adenoviral-vectored universal influenza vaccines administered intranasally reduce lung inflammatory responses upon viral challenge 15 months post-vaccinationJulia A Misplon, Chia-Yun Lo, Torrie A Crabbs, et al.
Vaccine|July 6, 2010
Genetic control of immune responses to influenza A matrix 2 protein (M2)Julia A Misplon, Chia-Yun Lo, Jon D Gabbard, et al.
Vaccine|July 6, 2021
Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in miceChia-Yun Lo, Julia A Misplon, Xing Li, et al.
Vaccine|December 19, 2017
Conventional influenza vaccines influence the performance of a universal influenza vaccine in miceJanelle Rowell, Chia-Yun Lo, Graeme E Price, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 11, 2011
Intranasal administration of adeno-associated virus type 12 (AAV12) leads to transduction of the nasal epithelia and can initiate transgene-specific immune responseKathrina Quinn, Mary R Quirion, Chia-Yun Lo, et al.
Vaccine|July 14, 2005
Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoproteinSuzanne L Epstein, Wing-pui Kong, Julia A Misplon, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2012
Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenzaNimalan Arinaminpathy, Oliver Ratmann, Katia Koelle, et al.
Plos One|April 16, 2019
The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in miceJanelle Rowell, Chia-Yun Lo, Graeme E Price, et al.
Pageof 4